Synergistically therapeutic effects of VEGF165 and angiopoietin-1 on ischemic rat myocardium. (Q50687785)

17 March 2018

title

Synergistically therapeutic effects of VEGF165 and angiopoietin-1 on ischemic rat myocardium. (English)

1 reference

17 March 2018

author name string

Xiang Liu

1

1 reference

17 March 2018

Yijiang Chen

2

1 reference

17 March 2018

Fumin Zhang

3

1 reference

17 March 2018

Lizhen Chen

4

1 reference

17 March 2018

Tuanzhu Ha

5

1 reference

17 March 2018

Xiang Gao

6

1 reference

17 March 2018

Chuanfu Li

7

1 reference

17 March 2018

publication date

1 April 2007

1 reference

17 March 2018

Scandinavian Cardiovascular Journal

published in

1 reference

17 March 2018

volume

41

1 reference

17 March 2018

issue

2

1 reference

17 March 2018

page(s)

95-101

1 reference

17 March 2018

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

The post-natal heart contains a myocardial stem cell population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

KDR receptor: a key marker defining hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Analysis of human TIE2 function on hematopoietic stem cells in umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Bone marrow stem cells regenerate infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Evidence that human cardiac myocytes divide after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430701197593

10.1080/14017430701197593

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018